Research and Development (R&D) Expenses: R&D expenses were $82.8 million for the fourth quarter of 2024, compared to $77.5 million for the fourth quarter of 2023, and $301.3 million for the full year ...

Phase III trial to assess the efficacy and safety of EscharEx® for debridement and facilitation of active wound closureInterim analysis planned ...

Analysis of the open label data from FLAMINGO-01 has commenced and has been conducted in a manner that maintains the study blind. A preliminary review of FLAMINGO-01 HLA data in both the HLA-A*02 ...

Pharmaceutical Market Size and Growth 2025 to 2034The global pharmaceutical market size was valued at USD 1,607.07 billion in ...

Harnessing Artificial Intelligence for Global Health Advancement. Journal of Data Analysis and Information Processing, 13, 66 ...

A name echoes through the corridors of Warsaw Citadel, the Polish capital's fortress where EU home affairs ministers ... where Trump's muscular example was very much front and centre.

Telethon Foundation is seeking approval for a gene therapy to treat the rare disease Wiskott-Aldrich syndrome.

A name echoes through the corridors of Warsaw Citadel, the Polish capital's fortress where EU home affairs ministers are discussing ... where Trump's muscular example was very much front and centre.

A name echoes through the corridors of Warsaw Citadel, the Polish capital's fortress where EU home affairs ministers are discussing how to crack down on irregular migration: that of Donald Trump.